drugset / Trial / NCT02065674

Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM

NCT02065674 ↗

Expanded access Available Fr Muller Homoeopathic Medical College

Summary

Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in changing the Glycated Hb Level in Diabetes mellitus Type II. Abstract: Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in the world in this century, and accounts for 90% of cases of diabetes globally. Studies have suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.

Timeline

Start
2014-02
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Abroma Augusta Traditional medicine (herbal / TCM) 30 unknown —